Skip to content

Incyte INCY Gross Profit

Gross Profit at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$8.07B-1.2%
Pfizer logo
PfizerPFE
$10.9B+0.3%
Gilead Sciences logo
Gilead SciencesGILD
$5.52B+7.6%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$19.43M+154%
AbbVie logo
AbbVieABBV
$10.78B+15.4%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$95.61M+67.7%

Other financials

Income statement

See full
Revenue$1.3B+20.9%
Operating income$301.1M+46.8%
Net income$303.3M+91.7%
EPS (diluted)$1.47+83.7%

Balance sheet

See full
Cash & equivalents$3.5B+78.2%
Total debt$39.4M-8.6%
Total equity$5.6B+53.3%
Total assets$7.3B+27.7%

Cash flow

See full
Operating cash flow$369.4M+38.8%
CapEx$1.6M-43.5%
Free cash flow$367.7M+39.7%

Valuation

See full
Market cap$23.32B+78.0%
Enterprise value$19.89B+77.9%
P/E16.3×+1.2×
P/S4.4×+1.5×

Profitability

See full
Gross margin92.5%-0.2pp
Operating margin30%+26.1pp
Net margin26.7%+26.2pp
FCF margin28.2%+19.7pp

Returns & leverage

See full
Return on equity30.8%+30.4pp
Debt / equity0.0×
Current ratio3.7×+1.6×

Where this comes from

Calculated from Incyte’s reported figures.

The official record: Incyte’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Incyte's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Incyte's gross profit?
Incyte (INCY) reported gross profit of $1.17B in Q1 2026.
How has Incyte's gross profit changed year-over-year?
Incyte's gross profit increased by 19.2% year-over-year, from $979.71M to $1.17B.
What is the long-term trend for Incyte's gross profit?
Over 4 years (2021 to 2025), Incyte's gross profit has grown at a 13.9% compound annual growth rate (CAGR), from $2.84B to $4.77B.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.